Page last updated: 2024-09-05

organophosphonates and Corneal Diseases

organophosphonates has been researched along with Corneal Diseases in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barron, AR; Doostdar, N; Hamill, MB; Manrique, CJ1
Banker, AS; Bergeron-Lynn, G; De Clercq, E; Flores-Aguilar, M; Freeman, WR; Keefe, K; Munguia, D; Rao, NA; Taskintuna, I; Wiley, CA1
Araullo-Cruz, T; De Clercq, E; Gordon, YJ; Romanowski, E1

Other Studies

3 other study(ies) available for organophosphonates and Corneal Diseases

ArticleYear
Synthesis of calcium-silica composites: a route toward an in vitro model system for calcific band keratopathy precipitates.
    Journal of biomedical materials research. Part A, 2011, Volume: 99, Issue:2

    Topics: Alkanes; Biocompatible Materials; Calcinosis; Calcium Carbonate; Corneal Diseases; Humans; Materials Testing; Molecular Structure; Organophosphonates; Phosphorous Acids; Silicic Acid; Silicon; Silicon Dioxide; Sodium Dodecyl Sulfate; Surface-Active Agents

2011
An animal model for cidofovir (HPMPC) toxicity: intraocular pressure and histopathologic effects.
    Experimental eye research, 1997, Volume: 64, Issue:5

    Topics: Animals; Cidofovir; Ciliary Body; Corneal Diseases; Cytosine; Disease Models, Animal; Eye Diseases; Guinea Pigs; Intraocular Pressure; Iritis; Microscopy, Electron; Organophosphonates; Organophosphorus Compounds; Pigment Epithelium of Eye; Retina; Retinal Diseases; Uveal Diseases

1997
Pretreatment with topical 0.1% (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine inhibits adenovirus type 5 replication in the New Zealand rabbit ocular model.
    Cornea, 1992, Volume: 11, Issue:6

    Topics: Adenoviridae; Adenoviridae Infections; Animals; Antiviral Agents; Cidofovir; Colony Count, Microbial; Corneal Diseases; Corneal Stroma; Cytosine; Disease Models, Animal; Eye Infections, Viral; Female; Ophthalmic Solutions; Organophosphonates; Organophosphorus Compounds; Premedication; Rabbits; Virus Replication

1992